Island Pharmaceuticals (ASX:ILA) ROE % Adjusted to Book Value : -14.00% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Island Pharmaceuticals ROE % Adjusted to Book Value?

Island Pharmaceuticals's ROE % for the quarter that ended in Dec. 2024 was -113.37%. Island Pharmaceuticals's PB Ratio for the quarter that ended in Dec. 2024 was 8.10. Island Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -14.00%.

Island Pharmaceuticals ROE % Adjusted to Book Value Historical Data

The historical data trend for Island Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Island Pharmaceuticals ROE % Adjusted to Book Value Chart

Island Pharmaceuticals Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

-9.34

-17.69

-21.03

-27.00

Island Pharmaceuticals Semi-Annual Data
	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial				-17.12	-23.59	-15.13	-49.36	-14.00

Competitive Comparison of Island Pharmaceuticals's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Island Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Island Pharmaceuticals's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Island Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Island Pharmaceuticals's ROE % Adjusted to Book Value falls into.

Island Pharmaceuticals ROE % Adjusted to Book Value Calculation

Island Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-173.37%	/	6.42
	=	-27.00%

Island Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-113.37%	/	8.10
	=	-14.00%

Island Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Island Pharmaceuticals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Island Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Island Pharmaceuticals Ltd (ASX:ILA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Bio101 Financial Advisory Pty Ltd, 697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.islandpharmaceuticals.com

Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its drug candidate ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases. The company carries out its research and development activities principally in the geographic regions of Australia and the United States of America.

Island Pharmaceuticals Headlines

No Headlines